NA

ID: ALA4462853

Chembl Id: CHEMBL4462853

PubChem CID: 155529765

Max Phase: Preclinical

Molecular Formula: C78H92ClN7O23

Molecular Weight: 1531.07

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](OC(=O)CCCc4cn(CCCCCC(=O)N(CCCC[C@H](NC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)O)Cc5ccc(Cl)cc5)nn4)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O

Standard InChI:  InChI=1S/C78H92ClN7O23/c1-45-56(41-78(103)68(108-72(100)51-26-15-9-16-27-51)66-76(6,57(89)40-58-77(66,44-104-58)109-47(3)88)67(94)64(105-46(2)87)62(45)75(78,4)5)106-73(101)65(63(49-22-11-7-12-23-49)82-69(95)50-24-13-8-14-25-50)107-61(93)31-21-28-53-43-86(84-83-53)39-19-10-17-30-59(90)85(42-48-32-34-52(79)35-33-48)38-20-18-29-54(70(96)97)80-74(102)81-55(71(98)99)36-37-60(91)92/h7-9,11-16,22-27,32-35,43,54-58,63-66,68,89,103H,10,17-21,28-31,36-42,44H2,1-6H3,(H,82,95)(H,91,92)(H,96,97)(H,98,99)(H2,80,81,102)/t54-,55-,56-,57-,58+,63-,64+,65+,66-,68-,76+,77-,78+/m0/s1

Standard InChI Key:  MQRGDBDFDQODNZ-ORSZZVITSA-N

Alternative Forms

1. Parent:

   

   ALA4462853

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 1531.07

Molecular Weight (Monoisotopic): 1529.5933

AlogP: ┄

#Rotatable Bonds: ┄

Polar Surface Area: ┄

Molecular Species: ┄

HBA: ┄

HBD: ┄

#RO5 Violations: ┄

HBA (Lipinski): ┄

HBD (Lipinski): ┄

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: ┄

CX LogP: ┄

CX LogD: ┄

Aromatic Rings: ┄

Heavy Atoms: ┄

QED Weighted: ┄

Np Likeness Score: ┄

References

1. Machulkin AE, Skvortsov DA, Ivanenkov YA, Ber AP, Kavalchuk MV, Aladinskaya AV, Uspenskaya AA, Shafikov RR, Plotnikova EA, Yakubovskaya RI, Nimenko EA, Zyk NU, Beloglazkina EK, Zyk NV, Koteliansky VE, Majouga AG..  (2019)  Synthesis and biological evaluation of PSMA-targeting paclitaxel conjugates.,  29  (16): [PMID:31248772] [10.1016/j.bmcl.2019.06.035]

Source

Source(1):

• Scientific Literature